ArticleIranian journal of child neurology2025
Determining Potential Risk Factors for Epilepsy in Children with Neonatal Hypoglycemia.
Article in Iranian journal of child neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The associations between epilepsy, metabolism, and their clinical implications.Frontiers in endocrinology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Identifying neonates at risk for hypoglycemia and establishing treatment protocols to prevent potential neurological complications are essential. This study aims to investigate the possible risk factors for epilepsy in children with a history of neonatal hypoglycemia in North Khorasan Province. Materials & Methods: This case-control study analyzed 64 children with a previous history of neonatal hypoglycemia between 2017 and 2021 in North Khorasan Province. Nineteen children with epilepsy were selected as the case group, and their MRI data were extracted from medical records. In the control group (45 individuals who did not develop epilepsy), children were randomly selected, and their data were also collected. The researchers completed the ages and stages questionnaire (ASQ) for both case and control groups at follow-up. Pregnancy, delivery, and neonatal health information was obtained from hospital records using a checklist. Statistical analysis was performed using SPSS v20, with data entry and coding accuracy ensured before analysis. Results: This case-control study was conducted on 64 children (19 with epilepsy and 45 without epilepsy) with neonatal hypoglycemia. The mean age for the case and control groups were 4.1 and 4.6 years, respectively. An association was observed between epilepsy prevalence (58%) and familial history (p<0.05). Children who developed epilepsy had more extended periods of hypoglycemia and NICU stays (p<0.05). The age when hypoglycemia starts has a significant impact on the development of epilepsy, with an eight times higher risk for every extra day of life at the time of hypoglycemia (p<0.05). The ASQ findings revealed significant deficiencies between case and control groups (p<0.05). MRI results demonstrated that ~82% of children with epilepsy displayed irregularities, predominantly gliosis, and encephalomalacia in the occipital area (abnormal pathologic findings). Conclusion: Neonatal hypoglycemia significantly raises the likelihood of developing epilepsy in later childhood. This risk is particularly high when the newborn requires an extended stay in the NICU, experiences delayed onset of hypoglycemia, or has a family history of epilepsy. Prompt recognition and focused intervention for newborns with these risk factors are essential to minimize the chances of developing epilepsy and related neurodevelopmental issues.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.